RAM Investment Partners’s Nurix Therapeutics NRIX Stock Holding History

RAM Investment Partners’s Portfolio NRIX Stock Details NRIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$419K	Hold	17,284	–	–	0.07%	71
2026 Q1	$268K	Hold	17,284	–	–	0.05%	97
2025 Q4	$328K	Hold	17,284	–	–	0.06%	78
2025 Q3	$160K	Hold	17,284	–	–	0.03%	103
2025 Q2	$197K	Hold	17,284	–	–	0.04%	95
2025 Q1	$205K	Hold	17,284	–	–	0.05%	88
2024 Q4	$326K	Hold	17,284	–	–	0.08%	68
2024 Q3	$388K	Hold	17,284	–	–	0.1%	55
2024 Q2	$361K	Buy	+17,284	New	+$269K	0.1%	57

Other funds holding NRIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VPC

Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

RAM Investment Partners's NRIX Position: Q2 2026 in Review

RAM Investment Partners held its Nurix Therapeutics (NRIX) position steady in Q2 2026 at 17,284 shares worth $419K. The position accounts for 0.07% of the portfolio, ranked #71.

RAM Investment Partners first reported a position in NRIX in Q2 2024 and has held it in 9 quarters since. 211 funds tracked by Wall St. Rank hold NRIX as of Q2 2026.

RAM Investment Partners held 17,284 shares of Nurix Therapeutics worth $419K as of Q2 2026.
RAM Investment Partners left its Nurix Therapeutics share count unchanged in Q2 2026.
Nurix Therapeutics made up 0.07% of RAM Investment Partners's portfolio in Q2 2026, its #71 holding.
RAM Investment Partners first reported a position in Nurix Therapeutics in Q2 2024 and has held it in 9 quarters since.
211 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q2 2026.

Based on RAM Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.